ASXL1 mutations are infrequent in young patients with primary acute myeloid leukemia and their detection has a limited role in therapeutic risk stratification

Author: El-Sharkawi Dima   Ali Akbar   Evans Catherine M.   Hills Robert K.   Burnett Alan K.   Linch David C.   Gale Rosemary E.  

Publisher: Informa Healthcare

ISSN: 1042-8194

Source: Leukemia and Lymphoma, Vol.55, Iss.6, 2014-06, pp. : 1326-1331

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content